(Q41485243)

1 October 2017

1 reference

title

Clinical chemistry and molecular biology of homocysteine metabolism: an update (English)

1 reference

1 October 2017

0 references

Miner SE

1

1 reference

PubMed ID

9167894

1 October 2017

Evrovski J

series ordinal

2

1 reference

PubMed ID

9167894

1 October 2017

Cole DE

series ordinal

3

1 reference

1 October 2017

1 April 1997

1 reference

1 October 2017

Clinical Biochemistry

1 reference

1 October 2017

30

1 reference

1 October 2017

3

1 reference

1 October 2017

189-201

1 reference

Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine induced endothelial cell toxicity and its protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia: an independent risk factor for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine and coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia in premature arterial disease: examination of cystathionine beta-synthase alleles at the molecular level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Plasma homocysteine and menopausal status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Health implications of Mediterranean diets in light of contemporary knowledge. 2. Meat, wine, fats, and oils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Prevalence of cobalamin deficiency in the Framingham elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Cobalamin absorption and serum homocysteine and methylmalonic acid in elderly subjects with low serum cobalamin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

High prevalence of cobalamin deficiency in elderly outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Pernicious anemia. The expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Diagnosis of megaloblastic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia and the response to vitamin supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Treatment of mild hyperhomocysteinemia in vascular disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Can lowering homocysteine levels reduce cardiovascular risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Folate conjugase activity in the plasma and tumors of breast-cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Net uptake of plasma homocysteine by the rat kidney in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocyst(e)ine and arterial occlusive diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Measurement of homocyst(e)ine in the prediction of arteriosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Further experience of vitamin supplementation for prevention of neural tube defect recurrences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Presence of the French Canadian deletion in a French patient with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Underlying disorders associated with severe early-onset preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Homocysteine metabolism in pregnancies complicated by neural-tube defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Neural tube defects and elevated homocysteine levels in amniotic fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Are patients with homocystinuria being missed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

The mechanism of inactivation of S-adenosylhomocysteinase by 2'-deoxyadenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

The effect of blood sample aging and food consumption on plasma total homocysteine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Regulatory role of oxidized and reduced pteroylpolyglutamates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

Vitamin nutrition status and homocysteine: an atherogenic risk factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2896%2900172-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(96)00172-5

1 reference

1 October 2017

1 reference

PubMed ID

9167894